ValueQ3, 24Q4, 24Q1, 25Q2, 25Q3, 25TTMSelling/general/admin expenses777 K927 K1.93 M1 M967 K4.83 MResearch & development7.13 M7.82 M11.62 M5.34 M5.08 M29.86 MOperating income7.9 M8.75 M13.55 M6.34 M6.05 M34.68 MNon-Operating Income, Total2.9 M-1.8 M2.69 M4.61 M141 K5.64 MInterest expense, net of interest capitalized——————Non-Operating Income, excl. Interest Expenses2.87 M-2.21 M1.7 M4.61 M56 K4.15 MUnusual income/expense25 K407 K995 K3 00085 K1.49 MPretax income5.01 M10.55 M10.86 M1.73 M5.91 M29.04 MEquity in earnings——————Taxes9 000-27 K29 K28 K102 K132 KNon-controlling/minority interest——————After tax other income/expense——————Net income before discontinued operations5.01 M10.51 M10.88 M1.76 M6.01 M29.16 MDiscontinued operations——————Net income5.01 M10.51 M10.88 M1.76 M6.01 M29.16 MDilution adjustment——————Preferred dividends——————Diluted net income available to common stockholders5.01 M10.51 M10.88 M1.76 M6.01 M29.16 MBasic earnings per share (Basic EPS)-0.16-0.34-0.36-0.06-0.2-0.96Diluted earnings per share (Diluted EPS)0.160.340.360.060.20.96Average basic shares outstanding30.47 M30.46 M30.49 M30.49 M30.49 M121.92 MDiluted shares outstanding30.47 M30.46 M30.49 M30.49 M30.49 M121.92 MEBITDA——————EBIT——————Cost of revenue——————Other cost of goods sold——————Depreciation & amortization (cash flow)439 K394 K442 K439 K427 K1.7 M
XBiotech Inc
XBiotech Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas. It specializes in the research and development of human-derived antibody therapeutics for multiple diseases, including cancer, rheumatological, and infectious diseases.